ZYGOMED

Active

Private limited companyfounded 20232 yrs activeDenis Verdonckstraat 16, 1070 Anderlecht, BelgiumKBO/BCE: BE 1002.030.289

ZYGOMED has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €121k and a net result of €117k. Its solvency ranks better than 43% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Watch Print / PDF

Checked score

Score 2024

88 / 100

Excellent

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability100▲+31

Solvency85▲+53

Growth78

Track record82

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €10k at 30 days only on tighter terms

Liquidity ample (current ratio 1.95 against 0.21 in 2023; cash: 81.4% of total assets), and 39.9% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 86

Relative position

BE, all sectors

reference

Sector 86

lower

← fewer bankruptcies more bankruptcies →

Young company

A young company has little track record yet and statistically fails more often than an established one.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Filed after the deadline

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 22-09-2025, 53 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 2 filings

Deviation from the deadline

2025

not confirmed

2024

53 d late

2023

37 d late

← before the deadline after the deadline →

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity

€121k▲ 2,913%

2023 · €4k

2023: €4k

2023 → 2024

Total assets

€201k▲ 267%

2023 · €55k

2023: €55k

2023 → 2024

Net result

€117k▲ 40,507%

2023 · €287

2023: €287

2023 → 2024

Working capital

€83k

2023 · €-40k

2023: €-40k

2023 → 2024

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20232024Trend

Equity€4k-€121k▲ 2,913%

Operating result€794-€153k▲ 19,159%

Net result€287-€117k▲ 40,507%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result rises in 2024; 2024 is 19,159% above 2023.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €201k

15.2%

84.8%

Fixed assets €30k▼ 30.7%

Current assets €170k▲ 1,495%

Equity and liabilities €208k

58.0%

42.0%

Equity €121k▲ 2,913%

Debt €87k▲ 72.4%

The debt ratio falls from 92.7% to 42.0%. Equity and debt are higher.

Key figures and ratios

2024 value · change against 2023

EBITDA

€169k▲

2023 · €3k

Cash flow

€132k▲

2023 · €2k

Solvency

60.1%▲

2023 · 7.3%

Current ratio

1.95▲

2023 · 0.21

Quick ratio

1.95▲

2023 · 0.21

Debt / equity

0.72▼

2023 · 12.65

ROE

96.7%▲

2023 · 7.2%

ROA

58.1%▲

2023 · 0.5%

Interest coverage

1063.70▲

2023 · 141.79

Debt

€87k▲

2023 · €51k

Debt ≤ 1 year

€87k▲

2023 · €50k

Income taxes

€36k▲

2023 · €486

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2024 against 2023

Balance sheet Code20232024

Assets

Total assets20/58€55k€201k▲

Fixed assets21/28€44k€30k▼

Tangible fixed assets22/27€44k€30k▼

Plant, machinery and equipment23€23k€16k▼

Furniture and vehicles24€21k€15k▼

Current assets29/58€11k€170k▲

Cash at bank and in hand54/58€2k€163k▲

Deferred charges and accrued income490/1€9k€7k▼

Equity and liabilities

Total equity and liabilities10/49€55k€201k▲

Equity10/15€4k€121k▲

Contributions10/11€4k€4k=

Profit (loss) carried forward14-€117k

Amounts payable17/49€51k€87k▲

Amounts payable within one year42/48€50k€87k▲

Trade debts44€2k€1k▼

Suppliers440/4€2k€1k▼

Taxes, remuneration and social security45€745€37k▲

Taxes450/3€745€37k▲

Other amounts payable47/48€47k€50k▲

Accrued charges and deferred income492/3€363-

Income statement Code20232024

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€16k▲

Other operating charges640/8-€1k

Gross operating margin9900€3k€170k▲

Operating profit (loss)9901€794€153k▲

Financial income75/76B-€70

Recurring financial income75-€70

Financial charges65/66B€21€159▲

Recurring financial charges65€21€159▲

Profit (loss) for the period before taxes9903€773€153k▲

Income taxes67/77€486€36k▲

Profit (loss) for the period9904€287€117k▲

Profit (loss) for the period to be appropriated9905€287€117k▲

Appropriation of the result

Profit (loss) to be appropriated9906€287€117k▲

Profit to be distributed694/7€287€833▲

Return on contributions (dividend)694€287€833▲

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 4Financial 2Filings 2

2025

22-09

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 53 days late

2024

31-12

Financial Liquidity times 9current ratio 1.95

Current ratio from 0.21 to 1.95.

31-12

Financial Equity above €100kEq €121k ▲2913%

2 profitable years in a row build equity to €121k.

06-09

NBB filing Annual accounts filed

fiscal year 2023 · micro schema · 37 days late

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Anderlecht · 1 establishment unit since 2023

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Denis Verdonckstraat 161070 Anderlecht

Ground area

242 m²

Building footprint

224 m²

Volume, LiDAR

2,444 m³

Parcel 21304B0023/00M007, Brussels · tallest building 12.7 m, ±4 floors. Linked by address, not a title deed.

1 establishment unit

ZYGOMED

Denis Verdonckstraat 16, 1070 AnderlechtSpecialist medical practice

since 20232.369.843.919

1 parcel

Brussels 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21304B0023/00M007	Brussels	242 m²	1 · 223 m²	12.7 m · 4 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

IT DENTAL

BE 1021.971.412

Nivelles · Eq €149k

Tandarts Samir Sakani

Of 78 companies in sector 86991 we hold annual accounts for 11. 7 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded07-11-2023

Fiscal year end31-12

Activities, NACEBEL

86991Human health activities

Sources

Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.